AB-1005 Long-Term Follow-up Study

AskBio Inc

Status: Invitation-only

Conditions: Parkinson's Disease; Multiple System Atrophy, Parkinson Variant

Treatments: Other: Observation

Study type: Observational

Funder types: Industry

Identifiers

NCT07081841

ASK-PD0-CS002

Details and patient eligibility

About

This is an observational, long term, follow-up study for participants with Parkinson's disease (PD) or Multiple System Atrophy-Parkinsonian subtype (MSA-P) who participated in prior interventional studies with AB-1005. It is intended to better understand the long-term safety of AB-1005, how well tolerated it is and how long lasting the effects are.

Enrollment: 132 estimated patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• PD and MSA-P participants that are or were enrolled in an interventional AB-1005 study and provide informed consent

Exclusion criteria

• There are no exclusion criteria

Trial design

132 participants in 2 patient groups

Participants with PD

Treatment:

Other: Observation

Participants with MSA-P

Treatment:

Other: Observation